GPR55
ENSG00000135898
Target class
GPCR
Chromosome
2
- Chemical probe available
- Yes
- Target name
- GPR55
- Gene name
- G protein-coupled receptor 55
- Gene symbol
- GPR55
- Protein name
- G-protein coupled receptor 55
- Gene biotype
- Protein coding
- Gene family
- G protein-coupled receptors, Class A orphans
- Target class
- GPCR
- Target type
- Human gene
- Tissues expressed in
- 6
- Highest tissue expression
- 19.53
- Tissue specificity (Gini)
- 0.815
- Tissue specificity (tau)
- 0.971
- KEGG gene identifiers
- hsa:9290
- Protein interaction confidence
- 0.818316
- Protein interaction partners
- 19
- R-HSA-373076
- R-HSA-418594
- End position
- 230961066
- Start position
- 230907318
- Chromosome
- 2
- Strand
- Reverse
- Cell membrane
- Multi-pass membrane protein .
Publication evidence
- PubMed 18757503
- Tissue specificity (tau)
- 0.970959
- Expression inequality (Gini)
- 0.814789
Expression in transcripts per million
- Cells - EBV-transformed lymphocytes
- 19.53
- Testis
- 8.41
- Spleen
- 4.88
- Small Intestine - Terminal Ileum
- 2.88
- Brain - Nucleus accumbens (basal ganglia)
- 1.49
Expression in transcripts per million
- Cells - EBV-transformed lymphocytes19.53
- Testis8.41
- Spleen4.88
- Small Intestine - Terminal Ileum2.88
- Brain - Nucleus accumbens (basal ganglia)1.49
- Brain - Caudate (basal ganglia)1.28
- Whole Blood0.88
- Brain - Cortex0.86
- Brain - Frontal Cortex (BA9)0.86
- Brain - Putamen (basal ganglia)0.78
- Colon - Transverse0.69
- Pituitary0.6
- Vagina0.53
- Brain - Anterior cingulate cortex (BA24)0.47
- Esophagus - Mucosa0.42
- Minor Salivary Gland0.39
- Lung0.34
- Esophagus - Gastroesophageal Junction0.3
- Stomach0.29
- Esophagus - Muscularis0.29
- Skin - Not Sun Exposed (Suprapubic)0.27
- Brain - Amygdala0.25
- Prostate0.22
- Cervix - Endocervix0.22
- Skin - Sun Exposed (Lower leg)0.21
And 29 more, listed on the interactive page.
- GO:0007186
- GO:0007200
- GO:0035025
- GO:0045453
- GO:0045671
- GO:0070374
Cellular components
- GO:0005886
- GO:0004930
- GO:0004949
- GO:0005515
Related records
Trials (534)
- 5-Way Crossover Study to Compare the Safety, Tolerability and Pharmacokinetics of New Oral Cannabinoid Formulations Administered as Single Doses, With Buccal Sativex®, in Healthy Volunteers
- A Clinical Trial of a Hemp-Derived, High Cannabidiol Product for Anxiety in Glioblastoma Patients
- A Clinical Trial on the Antipsychotic Properties of Cannabidiol
- A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy
- A Double-Blinded Study on Rapid and Sustained Pain Relief Topical Cannabidiol for Plantar Fasciitis
- A Four-week Clinical Trial Investigating Efficacy and Safety of Cannabidiol As a Treatment for Acutely Ill Schizophrenic Patients
- A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes
- A Laboratory Model of Increasing Delta-9-tetrahydrocannabinol (THC) Potency on Cigarette Smoking
- A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
- A Pharmacokinetic Study to Compare CBD-NE to Epidyolex in Healthy Adult Volunteers Under Both Fed and Fasted Conditions
- A Phase 2a Study to Evaluate the Safety and Efficacy of Cannabidiol Only as Maintenance Therapy and Steroid Sparing in Patients With Stable Autoimmune Hepatitis
- A Phase I/II Study to Evaluate Single Agent and Combination Therapy With Megestrol Acetate and Dronabinol for the Treatment of HIV-Wasting Syndrome
- A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas
- A Pilot Study of GWP42003 in the Symptomatic Treatment of Ulcerative Colitis (GWID10160)
- A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
- A Randomized Controlled Trial of Oral CBD for the Treatment of Upper Extremity Musculoskeletal Pain
- A RCT Comparing Dronabinol to a Placebo for Post-operative Pain in Total Joint Arthroplasty
- A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Migraines.
- A Study of Cannabidiol in Young Adult Cannabis Users
- A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain
Drugs (4)
- Cannabidiol
- Dronabinol
- Palmidrol
- Rimonabant